ALNYLAM PHARMACEUTICALS, INC. Comprehensive Income 2008-2025 | ALNY
Beta
What is comprehensive income?
Comprehensive income includes net income plus other comprehensive items like foreign currency adjustments and unrealized investment gains or losses.
What is ALNYLAM PHARMACEUTICALS, INC.'s current comprehensive income?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual comprehensive income for 2025 was $328.2M, a 213.44% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. comprehensive income for the quarter ending December 31, 2025 was $148.9M.
What was ALNYLAM PHARMACEUTICALS, INC.'s comprehensive income in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual comprehensive income for 2024 was $-289.3M, a 30.95% increase from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s comprehensive income in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual comprehensive income for 2023 was $-419.0M, a 63.33% increase from 2022.
Comprehensive Income History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGRN/A
FY2020
$-865.4M
→
FY2025
$328.2M
080910111213141516171819202122232425
5 years selected
Comprehensive Income History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $328.2M | +213.4% | 10-K |
| FY2024 | $-289.3M | +30.9% | 10-K |
| FY2023 | $-419.0M | +63.3% | 10-K |
| FY2022 | $-1.14B | -35.6% | 10-K |
| FY2021 | $-842.5M | +2.6% | 10-K |
| FY2020 | $-865.4M | +2.7% | 10-K |
| FY2019 | $-889.4M | -17.0% | 10-K |
| FY2018 | $-760.3M | -54.6% | 10-K |
| FY2017 | $-491.9M | -9.8% | 10-K |
| FY2016 | $-447.9M | -33.9% | 10-K |
| FY2015 | $-334.5M | -0.9% | 10-K |
| FY2014 | $-331.3M | -289.0% | 10-K |
| FY2013 | $-85.2M | +5.6% | 10-K |
| FY2012 | $-90.2M | -54.1% | 10-K |
| FY2011 | $-58.5M | -34.5% | 10-K |
| FY2010 | $-43.5M | +9.5% | 10-K |
| FY2009 | $-48.1M | -89.5% | 10-K |
| FY2008 | $-25.4M | - | 10-K |
Company: ALNYLAM PHARMACEUTICALS, INC.Ticker: ALNYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →